QUE Oncology Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $21.5M
Latest Deal Amount
  • Investors
  • 5

QUE Oncology General Information

Description

Developer of novel therapies designed to address debilitating women's health conditions. The company's therapies are focused on the treatment of hot flashes in breast cancer patients and survivors undergoing endocrine therapy, enabling doctors to treat the unmet medical needs of women.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 2870 Peachtree Road
  • Suite 466
  • Atlanta, GA 30305
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

QUE Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 05-Jun-2017 $21.5M 000.00 000.00 Completed Pre-Clinical Trials
1. Joint Venture 01-Jan-2013 Completed Product Development
To view QUE Oncology’s complete valuation and funding history, request access »

QUE Oncology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view QUE Oncology’s complete cap table history, request access »

QUE Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel therapies designed to address debilitating women's health conditions. The company's therapies are foc
Drug Discovery
Atlanta, GA
000.00
00.00 0000-00-00
00000000000 000.00

0000000

lla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mol
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

QUE Oncology Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
You’re viewing 1 of 1 competitors. Get the full list »

QUE Oncology Executive Team (5)

Name Title Board Seat Contact Info
Julie Cherrington Ph.D Chief Executive Officer & Board Member
Greg Wilson Consulting Chief Financial Officer
You’re viewing 2 of 5 executive team members. Get the full list »

QUE Oncology Board Members (7)

Name Representing Role Since
Chris Nave Ph.D The Medical Research Commercialisation Fund Chairman 000 0000
Dennis Liotta Ph.D Centrosome Ventures Board Member 000 0000
Elizabeth Cermak QUE Oncology Board Member 000 0000
John Richard Ph.D Self Board Member 000 0000
Julie Cherrington Ph.D Self Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

QUE Oncology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Centrosome Ventures Venture Capital Minority 000 0000 000000 0
The Medical Research Commercialisation Fund Venture Capital Minority 000 0000 000000 0
Uniseed Venture Capital Minority 000 0000 000000 0
Emory University Department of Human Genetics Corporation Minority 000 0000 000000 0
Uniquest Accelerator/Incubator Minority 000 0000 000000 0
To view QUE Oncology’s complete investors history, request access »